| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2022 , Vol 60 , Num 4
Grewia asiatica Linn. root extract loaded suspension, microparticulate and nanosuspension dosage form: Fabrication, characterization and anthelmintic evaluation
1 Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh 123031 (Haryana), India2 Drug Delivery Research laboratory, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001 (Haryana), India
DOI : 10.23893/1307-2080.APS6024 Viewed : 8123 - Downloaded : 2288 The current study was planned to formulate the Grewia asiatica Linn. root extract loaded herbal formulation and evaluated its potential for in vitro anthelmintic activity. The root extract of Grewia asiatica Linn. was standardized by HPTLC using quercetin and naringenin, as a marker compound. The extract was formulated into a novel microparticulate and nanosuspension dosage form based on the Eudragit S100. The prepared dosage forms were characterized by particle size, morphology, and in vitro release behavior. Further, the comparative evaluation of dosage form revealed the presence of higher in vitro anthelmintic activity in nanosuspension as compared to conventional suspension and microparticulate dosage form. Keywords : Grewia asiatica; nanosuspension; microparticles; suspension; anthelmintic